– NETHERLANDS, Eindhoven – ONWARD Medical N.V. (EPA: ONWD / OTC: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury, announced the appointment of Lucas Buchanan to its Board as a Non-Executive Director.
About Lucas Buchanan
Lucas Buchanan brings over 25 years of expertise in commercialization, operations, business development, investing, and finance. As COO and CFO at Silk Road Medical, he helped lead the company from its founding through to its IPO in 2019 and ultimate sale to Boston Scientific in 2024. Buchanan previously held roles at The Vertical Group, Impax Laboratories, Warburg Pincus, Medtronic, and Ernst & Young.
Lucas Buchanan is an active investor who currently serves on the Boards of Directors for several medical technology companies, including Element Science, Aerin Medical, Route 92 Medical, Procyrion, and Endologix.
Lucas Buchanan holds a BA in Economics from Duke University and an MBA in Health Care Management from The Wharton School at the University of Pennsylvania.
About ONWARD Medical
ONWARD Medical is the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities. Building on more than a decade of scientific discovery, preclinical research, and clinical studies conducted at leading hospitals, rehabilitation clinics, and neuroscience laboratories, the Company has developed ARC Therapy, which has been awarded ten Breakthrough Device Designations from the US Food and Drug Administration (FDA). The Company’s ARC-EX System is cleared for commercial sale in the US. In addition, the Company is developing an investigational implantable system called ARC-IM with and without an implanted brain-computer interface (BCI).
Headquartered in the Netherlands, the Company has a Science and Engineering Center in Switzerland and a US office in Boston, Massachusetts. The Company is listed on Euronext Paris, Brussels, and Amsterdam (ticker: ONWD), and its US ADRs can be traded on OTCQX (ticker: ONWRY).
For more: https://www.onwd.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.